In vitro activity of ceftaroline and comparator agents against Gram-positive and Gram-negative clinical isolates from cancer patients

Keyphrases

• Cancer Patients 100%
• In Vitro Activity 100%
• Gram-negative 100%
• Gram-positive 100%
• Ceftaroline 100%
• Gram-positive Organisms 60%
• Vancomycin 40%
• Linezolid 40%
• MIC90 40%
• Daptomycin 40%
• Tigecycline 40%
• In Cancer 20%
• Minimum Inhibitory Concentration 20%
• Methicillin-resistant S. Aureus 20%
• Escherichia Coli 20%
• Methicillin-resistant Staphylococcus Aureus 20%
• Streptococcus Pneumoniae 20%
• Enterobacter Cloacae 20%
• Klebsiella 20%
• Cephalosporins 20%
• Gram-negative Bacilli 20%
• Trimethoprim-sulfamethoxazole (TMP-SMX) 20%
• Coagulase-negative Staphylococci (CoNS) 20%
• Methicillin Resistance 20%
• Bacterial Infection 20%
• Proteus Mirabilis 20%
• Viridans Streptococci 20%
• Gram-negative Organisms 20%
• Methicillin-resistant Coagulase-negative Staphylococci 20%
• Moderate Activity 20%
• Extended-spectrum-lactamase 20%
• Micrococcus 20%
• Serratia 20%
• Bacillus Sp 20%
• Corynebacterium 20%
• Streptococcus Spp 20%
• Blood Culture Isolates 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Ceftaroline 100%
• Gram Positive Bacterium 60%
• Meticillin 40%
• Gram Negative Bacterium 40%
• Coagulase Negative Staphylococcus 40%
• Vancomycin 40%
• Linezolid 40%
• Streptococcus 40%
• Daptomycin 40%
• Tigecycline 40%
• Streptococcus pneumonia 20%
• Minimum Inhibitory Concentration 20%
• Staphylococcus aureus 20%
• Methicillin-Resistant Staphylococcus Aureus 20%
• Methicillin Susceptible Staphylococcus Aureus 20%
• Escherichia coli 20%
• Penicillinase 20%
• Klebsiella 20%
• Enterobacter Cloacae 20%
• Bacterial Infection 20%
• Cotrimoxazole 20%
• Cephalosporin 20%
• Proteus mirabilis 20%
• Micrococcus 20%
• Corynebacterium 20%
• Extended Spectrum Beta Lactamase 20%
• Serratia 20%